# Cefoxitin

NDC: 25021-111
Generic name: cefoxitin
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20100812

FDA application: ANDA065415

## Active ingredients

- CEFOXITIN SODIUM: 10 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-111"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-111
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c6f7665-204f-6c69-7669-61204d756e6e